1.Intestinal ultrasonography and fecal calprotectin for monitoring inflammation of ileal Crohn’s disease: two complementary tests
José María PAREDES ; Tomás RIPOLLÉS ; Ángela ALGARRA ; Rafael DIAZ ; Nadia MORENO ; Patricia LATORRE ; María Jesús MARTÍNEZ ; Pilar LLOPIS ; Antonio LÓPEZ ; Eduardo MORENO-OSSET
Intestinal Research 2022;20(3):361-369
Background/Aims:
Tight control of inflammation and adjustment of treatment if activity persists is the current strategy for the management of Crohn’s disease (CD). The usefulness of fecal calprotectin (FC) in isolated involvement of the small intestine in CD is controversial. To assess the usefulness of FC to determine the inflammatory activity detected by intestinal ultrasonography (IUS) in ileal CD.
Methods:
Patients with exclusively ileal involvement CD who underwent IUS and an FC were prospectively included. Simple ultrasound index was used to determine inflammatory activity. The usual statistical tests for comparison of diagnostic techniques were used.
Results:
One hundred and five patients were included, IUS showed inflammatory activity in 59% of patients and complications in 18.1%. FC showed a significant correlation with IUS in the weak range (Spearman coefficient r=0.502; P<0.001); the area under the receiver operating characteristic curve was 0.79 (95% confidence interval, 0.70–0.88; P<0.001). The FC value that best reflected the activity in IUS was 100 μg/g with sensitivity, specificity, and positive and negative predictive values of 73.0%, 71.4%, 79.3% and 63.8%, respectively. There were no differences in FC concentration between patients with or without transmural complications. The addition of serum C-reactive protein to FC did not improve the ability to assess IUS activity.
Conclusions
FC has a significant correlation with IUS to monitor ileal CD activity. This correlation is weak and it does not allow assessing the presence of CD complications. Both tests should be used in conjunction for tight control of ileal CD. More studies on noninvasive tests in this location are needed.
2.Transvaginal ultrasound evaluation of the ureter
Juan Ramón Pérez VIDAL ; Carmen Llanos LLANOS ; Inmaculada Gómez CARRASCOSA ; María Orenes MORENO ; Pilar Marín SÁNCHEZ
Obstetrics & Gynecology Science 2022;65(4):382-383
Objective:
In this video, we present our technique for ureter assessment during pelvic ultrasound examination.
Methods:
We used a general electric Voluson E10 (General electric, Wauwatosa, WI, USA) to perform transvaginal ultrasonography. These images were shared after thorough counselling, and obtaining informed consent from the patient. This video was edited using FinalCut ProX® (Apple Inc, Cupertino, CA, USA).
Results:
We systematized this routine after assessing the cervix, uterus, and adnexa. The vaginal probe was slightly removed to focus on the urethra. Next, we approached the hand on the contralateral thigh to the ureter. At this point, the probe was directed to the lateral pelvic wall where the ureteric orifice was found. Then, we raised our hands and perform an internal rotation movement to ascend the ureteral segments until it is related to the iliac vessels.
Conclusion
The urinary tract may be involved in gynecological pathologies. Transvaginal ultrasound is an easy, reproducible, and well-tolerated examination that can be used to evaluate the ureters below the pelvic brim.
3.Therapeutic Effects of Resiniferatoxin Related with Immunological Responses for Intestinal Inflammation in Trichinellosis.
José Luis MUÑOZ-CARRILLO ; José Luis MUÑOZ-LÓPEZ ; José Jesús MUÑOZ-ESCOBEDO ; Claudia MALDONADO-TAPIA ; Oscar GUTIÉRREZ-CORONADO ; Juan Francisco CONTRERAS-CORDERO ; María Alejandra MORENO-GARCÍA
The Korean Journal of Parasitology 2017;55(6):587-599
The immune response against Trichinella spiralis at the intestinal level depends on the CD4⁺ T cells, which can both suppress or promote the inflammatory response through the synthesis of diverse cytokines. During the intestinal phase, the immune response is mixed (Th1/Th2) with the initial predominance of the Th1 response and the subsequent domination of Th2 response, which favor the development of intestinal pathology. In this context, the glucocorticoids (GC) are the pharmacotherapy for the intestinal inflammatory response in trichinellosis. However, its therapeutic use is limited, since studies have shown that treatment with GC suppresses the host immune system, favoring T. spiralis infection. In the search for novel pharmacological strategies that inhibit the Th1 immune response (proinflammatory) and assist the host against T. spiralis infection, recent studies showed that resiniferatoxin (RTX) had anti-inflammatory activity, which decreased the serum levels of IL-12, INF-γ, IL-1β, TNF-α, NO, and PGE₂, as well the number of eosinophils in the blood, associated with decreased intestinal pathology and muscle parasite burden. These researches demonstrate that RTX is capable to inhibit the production of Th1 cytokines, contributing to the defense against T. spiralis infection, which places it as a new potential drug modulator of the immune response.
Cytokines
;
Drug Therapy
;
Eosinophils
;
Glucocorticoids
;
Immune System
;
Inflammation*
;
Interleukin-12
;
Parasites
;
Pathology
;
T-Lymphocytes
;
Therapeutic Uses*
;
Trichinella spiralis
;
Trichinellosis*
4.Comparison of the characteristics of canine adipose tissue-derived mesenchymal stem cells extracted from different sites and at different passage numbers
Kevin M YANESELLI ; Cristiana P KUHL ; Paula B TERRACIANO ; Fernanda S DE OLIVEIRA ; Sabrina B PIZZATO ; Kamila PAZZA ; Alessandra B MAGRISSO ; Vanessa TORMAN ; Analía RIAL ; María MORENO ; Silvia LLAMBÍ ; Elizabeth CIRNE-LIMA ; Jacqueline MAISONNAVE
Journal of Veterinary Science 2018;19(1):13-20
Mesenchymal stem cells (MSCs) have desirable characteristics for use in therapy in animal models and veterinary medicine, due to their capacity of inducing tissue regeneration and immunomodulation. The objective of this study was to evaluate the differences between canine adipose tissue-derived MSCs (AD-MSCs) extracted from subcutaneous (Sc) and visceral (Vs) sites. Surface antigenic markers, in vitro differentiation, and mineralized matrix quantification of AD-MSCs at different passages (P₄, P₆, and P₈) were studied. Immunophenotypic analysis showed that AD-MSCs from both sites were CD44+, CD90+, and CD45−. Moreover, they were able, in vitro, to differentiate into fat, cartilage, and bone. Sc-AD-MSCs preserve in vitro multipotentiality up to P₈, but Vs-AD-MSCs only tri-differentiated up to P₄. In addition, compared to Vs-AD-MSCs, Sc-AD-MSCs had greater capacity for in vitro mineralized matrix synthesis. In conclusion, Sc-AD-MSCs have advantages over Vs-AD-MSCs, as Sc AD-MSCs preserve multipotentiality during a greater number of passages, have more osteogenic potential, and require less invasive extraction.
Antigens, Surface
;
Cartilage
;
Immunomodulation
;
Immunophenotyping
;
In Vitro Techniques
;
Mesenchymal Stromal Cells
;
Miners
;
Models, Animal
;
Regeneration
;
Veterinary Medicine
5.The Value of Transcranial Doppler Sonography in Hyperperfusion Syndrome after Carotid Artery Stenting: A Nationwide Prospective Study
Francisco MONICHE ; Irene ESCUDERO-MARTÍNEZ ; Fernando MANCHA ; Alejandro TOMASELLO ; Marc RIBÓ ; Fernando DELGADO-ACOSTA ; Juán José OCHOA ; Joaquín GIL ; Rosario GIL ; Montserrat GONZÁLEZ-DELGADO ; Eduardo MURIAS ; Alain LUNA ; Alberto GIL ; Sonia MOSTEIRO ; María Dolores FERNÁNDEZ-COUTO ; Luis Fernández de ALARCÓN ; José M. RAMÍREZ-MORENO ; Joaquín ZAMARRO ; Guillermo PARRILLA ; José L. CANIEGO ; Gustavo ZAPATA-WAINBERG ; Andrés GONZÁLEZ-MANDLY ; José A. de las HERAS ; Luis LÓPEZ-MESONERO ; Joaquín ORTEGA ; Juan F. ARENILLAS ; Ernesto GARCÍA ; Pedro P. ALCÁZAR ; Elena ZAPATA-ARRIAZA ; Asier de ALBÓNIGA-CHINDURZA ; Juan Antonio CABEZAS ; Pilar ALGABA ; Aurelio CAYUELA ; Joan MONTANER ; Alejandro González GARCÍA
Journal of Stroke 2020;22(2):254-257
6.Erratum to: Aqueous extracts from Tenebrio molitor larval and pupal stages inhibit early hepatocarcinogenesis in vivo.
Dulce María MORENO-GARCÍA ; Armando ZEPEDA-BASTIDA ; Juan OCAMPO-LÓPEZ ; Brisa Rodope ALARCÓN-SÁNCHEZ ; Osiris Germán IDELFONSO-GARCÍA ; Sandra ROSAS-MADRIGAL ; Diana Ivette APARICIO-BAUTISTA ; Julio Isael PÉREZ-CARREÓN ; Saúl VILLA-TREVIÑO ; Jaime ARELLANES-ROBLEDO
Journal of Zhejiang University. Science. B 2023;24(4):371-372
Following an Assessment by the Autonomous University of Hidalgo State and the National Institute of Genomic Medicine, this erratum corrects the authorship of this article by adding Dulce María MORENO-GARCÍA as the first author.